SWISS to Cure DIPG

Wegbeschreibung Website

SWISS to Cure DIPG To accelerate viable treatments for DIPG: the deadliest disease for children around the world.

Some progress with Sonodynamic for GBM mainly though.  https://www.prnewswire.com/.../alpheus-medical-initiates...  Just...
12/04/2026

Some progress with Sonodynamic for GBM mainly though. https://www.prnewswire.com/.../alpheus-medical-initiates... Just for tracking so far, as they need some machine/process modifications to focus on and treat DIPG (some DMGs might be easier and targetable: function of location and/or resectability)

404

21/12/2025

From hospital hallways to conference stages across the country, Tough2gether is proud to be a trusted presence in the healthcare industry.
In 2025, we continued paving the way for stronger communication and collaboration among institutions, researchers, clinicians, advocates, and families.
By attending and hosting conferences nationwide, we help bridge gaps, spark new partnerships, and uncover emerging areas for research that bring us closer to better outcomes for kids facing childhood cancer.
These moments represent more than meetings - they represent progress, shared purpose, and hope built together.
Together, we fuel the fight. Together, we move research forward. Together, we give hope.
GIVE HOPE: tinyurl.com/t2g-givehope

Some progress in BBB opening with focused Ultrasound. What drug combinations could now really target individual DIPGs an...
21/12/2025

Some progress in BBB opening with focused Ultrasound. What drug combinations could now really target individual DIPGs and how do we get those approved as customized trial.

A research team recently published results from a first-in-pediatrics clinical trial demonstrating the safety and feasibility of using focused ultrasound for blood–brain barrier opening and drug delivery without the need for sedation.

Adresse

Zürich

Benachrichtigungen

Erfahren Sie als Erste/r von Neuigkeiten und Aktionen: Wir schicken Ihnen eine E-Mail, wenn SWISS to Cure DIPG etwas veröffentlicht. Ihre E-Mail-Adresse wird für keinen anderen Zweck verwendet, und Sie können sich jederzeit abmelden.

Verknüpfungen

Teilen